Nitacure 

Presentation: Nitacure, available in Bangladesh, contains Nitazoxanide. It is available in tablet form, typically 500 mg, and as a powder for oral suspension, which when reconstituted usually provides a concentration of 100 mg/5 ml.

Indications: Nitacure (Nitazoxanide) is indicated for the treatment of diarrhea caused by:

• Cryptosporidium parvum
• Giardia lamblia
• Entamoeba histolytica It may also be used for the treatment of certain worm infections as determined by a healthcare professional.

Dosage and Administration: Nitacure should be administered orally with food to enhance absorption. The dosage depends on the age of the patient and the specific infection being treated.

• Tablets (500 mg):
  • Adults and children over 12 years: One 500 mg tablet every 12 hours for 3 days.
• Oral Suspension (100 mg/5 ml):
  • Children 1-3 years: 5 ml (1 teaspoonful) every 12 hours for 3 days.
  • Children 4-11 years: 10 ml (2 teaspoonfuls) every 12 hours for 3 days.
  • Adults and children over 12 years: 25 ml (5 teaspoonfuls) or one 500 mg tablet every 12 hours for 3 days.

The oral suspension should be shaken well before use. Always follow the specific instructions provided by your physician for the correct dosage and duration of treatment.

Side Effects: The most frequently reported side effects with Nitacure (Nitazoxanide) are abdominal pain, vomiting, and headache. These side effects are typically mild and transient. Less frequent side effects may include nausea, anorexia, flatulence, and discolored urine. Very rare side effects can include increased appetite, enlarged salivary glands, increased creatinine and SGPT levels, pruritus, rhinitis, sweating, and dizziness.

Precautions: Nitacure (Nitazoxanide) is contraindicated in patients with known hypersensitivity to Nitazoxanide or any components of the preparation. Caution should be exercised when administering Nitacure concurrently with other highly plasma protein-bound drugs with narrow therapeuticindices, such as warfarin. Nitacure should be administered with caution to patients with hepatic, biliary, or renal disease.

Use in Pregnancy and Breastfeeding: There are no adequate and well-controlled studies in pregnant women. Nitacure should be used during pregnancy only if clearly needed. Nitazoxanide has been shown to be excreted in human milk, so caution should be exercised when administered to a nursing woman.

Storage: Keep in a dry place away from light and heat. The oral suspension should be stored according to the instructions on the packaging, usually below 30°C and protected from freezing. Keep out of the reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.